x

Global Vitamin K Antagonists (VKA) Market Analysis & Forecast 2019

Published Date: 2019-02-06   |   Pages: 102   |   Tables: 114   | Report Id: 969829   | Hits: 56 |   Pharma & Healthcare

category cover


Vitamin K is a kind of substance with biological activity of leaf green quinone.

Rising demand from Asia-Pacific region a major driver for the growth of the market.


The global Vitamin K Antagonists (VKA) market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Vitamin K Antagonists (VKA) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Vitamin K Antagonists (VKA) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.


The following manufacturers are covered:

Sanofi

Bristol-Myers Squibb

Bayer

Johnson & Johnson

Genentech (Roche)

Boehringer Ingelheim

Lilly

Daiichi Sankyo

Otsuka

AstraZeneca

Pfizer

Aspen

The Medicines Company


Segment by Regions

North America

Europe

China

Japan


Segment by Type

Oral Vitamin K Antagonists

Injection Vitamin K Antagonists


Segment by Application

VTE

ACS/MI

AF

Others

Licenses Type

Only one user can access the report
Multiple users can access the report

Why QYR

 Fastest report delivery service
 More than 10 years of vast experience
 Operational for 24 * 7 & 365 days
 In-depth and comprehensive analysis
 Excellent after sales support
 Owns large database

Need Help ?

Global Vitamin K Antagonists VKA market

QYR Clients

  • csl
  • croozer
  • crital alert
  • cristal
  • corveneng
  • coperion
  • contijpi medical
  • compass minerals
More Clients...